首页> 外文期刊>Global Health Action >Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
【24h】

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India

机译:印度孟买的二线治疗失败和三线抗逆转录病毒治疗的初步经验

获取原文

摘要

BackgroundThere are limited data on the failure of second-line antiretroviral therapy (ART) and the use of third-line ART in people living with HIV in resource-limited settings. Since 2011, the Médecins Sans Frontières (MSF) HIV/tuberculosis programme in Mumbai, India, has been providing third-line ART to patients in care.ObjectiveTo describe the experiences and programmatic challenges during management of suspected second-line ART failure and third-line ART therapy for patients living with HIV, including the use of HIV viral load (VL) testing.DesignThis was a retrospective, observational cohort study of patients with suspected second-line ART treatment failure, who were followed for at least 12 months between January 2011 and March 2014.ResultsA total of 47 patients with suspected second-line failure met the inclusion criteria during the study period. Twenty-nine of them (62%) responded to enhanced adherence support, had a subsequent undetectable VL after a median duration of 3 months and remained on sec...
机译:背景技术在资源有限的环境中,二线抗逆转录病毒疗法(ART)失败和在HIV感染者中使用三线抗逆转录病毒疗法的数据有限。自2011年以来,印度孟买的无国界医生(MSF)艾滋病毒/结核病计划一直在为护理中的患者提供三线抗病毒治疗。目的描述可疑二线抗病毒治疗失败和三线抗病毒治疗的经验和方案挑战。一线治疗HIV感染者的ART疗法,包括使用HIV病毒载量(VL)测试。设计这是一项回顾性观察性队列研究,研究对象是疑似二线ART治疗失败的患者,在一月之间至少随访了12个月2011年和2014年3月。结果在研究期间,共有47名疑似二线衰竭患者符合纳入标准。其中有29名(62%)对增强的依从性支持做出了反应,中位时间为3个月后,随后出现了无法检测到的VL,并持续了2个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号